Aslani, Jack Perez .

HRN: 22-76-89  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/19/2025
CEFTRIAXONE 1G (VIAL)
10/19/2025
10/26/2025
IV
1gm
Q24
PCAP C
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  PneumoniaBloodstreamProphylaxis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: